SMS Pharmaceuticals Revises 38th AGM Date to Sept 29, Sets Record Date for Dividend
SMS Pharmaceuticals has rescheduled its 38th AGM to September 29, 2026. The record date for dividend eligibility is now September 22, 2026. Book closure is from September 23 to September 29, 2026.
The change in AGM and record date is a procedural update and does not inherently impact the company's business operations or financial performance.
The announcement is a routine update regarding the rescheduling of an AGM and record date, with no positive or negative financial implications mentioned.
SMS Pharmaceuticals Limited has announced a revision in the date of its 38th Annual General Meeting (AGM), originally scheduled for September 23, 2026, to Tuesday, September 29, 2026. This change, approved by the Board of Directors due to administrative and scheduling constraints, will also affect the book closure and record date.
The company's Register of Members and Share Transfer Books will now remain closed from Wednesday, September 23, 2026, to Tuesday, September 29, 2026, inclusive, for the purpose of the 38th AGM. Consequently, the record date for determining eligible members to receive the dividend for the financial year 2025-26 has been revised to Tuesday, September 22, 2026, instead of the previously announced September 16, 2026. The dividend, if approved at the AGM, will be paid within the stipulated time period. The AGM will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM).
All other details from the company's previous intimation dated July 31, 2026, remain unchanged.
What to do with a filing like this
SMS Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SMS Pharmaceuticals Limited. Read the original for the full detail.